Péptidos

Peptide 5TAMRA-KKRYDREFLLGFQF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using 5TAMRA-KKRYDREFLLGFQF-OH include the following: Stabilizing the eIF4G1 alpha-helix increases its binding affinity with eIF4E: implications for peptidomimetic design strategies CJ Brown , JJ Lim, T Leonard, HCA Lim - Journal of molecular , 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022283610011757 Crystallization of eIF4E complexed with eIF4GI peptide and glycerol reveals distinct structural differences around the cap-binding site CJ Brown , CS Verma , MD Walkinshaw , DP Lane - Cell Cycle, 2009 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/cc.8.12.8742

A synthetic peptide for use as a blocking control in assays to test for specificity of KLHDC3 antibody, catalog no. 70R-9181

Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool

Peptide H-FLHVTYVPA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FLHVTYVPA-OH include the following: SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design SK Kushwaha , V Kesarwani, S Choudhury , S Gandhi - Genomics, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0888754320311149 In silico screening of prospective MHC class I and II restricted T-cell based epitopes of the spike protein of SARS-CoV-2 for designing of a peptide vaccine for COVID K Sarma, NK Bali, N Sarmah, B Borkakoty - COVID, 2022 - mdpi.comhttps://www.mdpi.com/2673-8112/2/12/124

Peptide H-DSLYLQMNSLR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DSLYLQMNSLR^-OH include the following: Simplifying MS-MRD in the Blood of Multiple Myeloma Patients with an Off-the-Shelf Calibrator P Langerhorst, C Wijnands - A new era in M , 2023 - repository.ubn.ru.nlhttps://repository.ubn.ru.nl/bitstream/handle/2066/296434/296434.pdf?sequence=1#page=89 M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibrator C Wijnands, P Langerhorst , S Noori - Clinical Chemistry and , 2024 - degruyter.comhttps://www.degruyter.com/document/doi/10.1515/cclm-2023-0781/html

Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool

Peptide H-MGTSSTDSQQAGHRRCSTSN-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-MGTSSTDSQQAGHRRCSTSN-OH include the following: Synthetic cementum protein 1-derived peptide regulates mineralization in vitro and promotes bone regeneration in vivo R Correa , J Arenas , G Montoya, L Hoz - The FASEB , 2019 - Wiley Online Libraryhttps://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fj.201800434RR Regeneration of rat periodontium by cementum protein 1-derived peptide L Hoz, S Lopez, M Zeichner-David - Journal of Periodontal , 2021 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/jre.12921 Cementum protein 1-derived peptide (CEMP 1-p1) modulates hydroxyapatite crystal formation in vitro G Montoya, R Correa , J Arenas , L Hoz - Journal of Peptide , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.3211 M. en C. MIKADO ALEJANDRO NIDOME CAMPOS ER ARaca‰VALO - 2023 - ru.dgb.unam.mxhttps://ru.dgb.unam.mx/bitstream/20.500.14330/TES01000838431/3/0838431.pdf PAPEL DE UN Paca‰PTIDO DERIVADO DE LA PROTEacaNA DE ADHESIaca“N DEL CEMENTO RADICULAR (HACD1/CAP) EN LA FUNCIONALIZACIaca“N DE CDGDELCU CUETO, C TUTOR - ru.dgb.unam.mxhttps://ru.dgb.unam.mx/bitstream/20.500.14330/TES01000802854/3/0802854.pdf

Peptide H-ASTASKGRYIPPHLRNKEAS-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ASTASKGRYIPPHLRNKEAS-OH include the following: The AZFa gene DBY (DDX3Y) is widely transcribed but the protein is limited to the male germ cells by translation control HJ Ditton, J Zimmer, C Kamp - Human molecular , 2004 - academic.oup.comhttps://academic.oup.com/hmg/article-abstract/13/19/2333/617632

Clickable TAT peptide.

A synthetic peptide for use as a blocking control in assays to test for specificity of RPS6KB1 antibody, catalog no. 70R-3693

A synthetic peptide for use as a blocking control in assays to test for specificity of PSEN1 antibody, catalog no. 70R-6264

Peptide H-VNFYAWK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VNFYAWK-OH include the following: Erythropoietin production by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation Y Yasuoka, T Fukuyama, Y Izumi - Physiological , 2020 - Wiley Online Libraryhttps://physoc.onlinelibrary.wiley.com/doi/abs/10.14814/phy2.14485 Screen and confirmation of PEG-epoetin beta in equine plasma Y Chang, GM Maylin, G Matsumoto - Drug Testing and , 2011 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/dta.212 Fast confirmatory analysis of rHuEPOs in plasma for horseracing doping control by coupling Evosep One & Q-Exactive HF V Delcourt , P Garcia , B Chabot, M Caroff, N Bache - evosep.comhttps://www.evosep.com/wp-content/uploads/2019/03/EPO_app-note-march-2019.pdf Structure-based comprehensive identification of erythropoiesis-stimulating agents and their biosimilars T Otsuki, Y Kishikawa, H Suzuki, M Ueki - Forensic Toxicology, 2014 - Springerhttps://link.springer.com/article/10.1007/s11419-014-0225-x Peptide mapping study on human erythropoietin (EPO): a complex N-and O-linked glycoprotein S Heidelberger, X Bi, Z Chen, Z Zhang, K Pohl - sciex.comhttps://www.sciex.com/content/dam/SCIEX/pdf/tech-notes/biopharma/epo-n-and-o-glycopeptides-zenotof7600.pdf Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid NH Yu, ENM Ho, TSM Wan, ASY Wong - Analytical and bioanalytical , 2010 - Springerhttps://link.springer.com/article/10.1007/s00216-010-3455-8 Monitoring recombinant human erythropoietin abuse among athletes M Citartan , SCB Gopinath , Y Chen - Biosensors and , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S095656631400493X La spectrometrie de masse dans le contracaÂŽle antidopage M Audran, E Varlet-Marie - Revue Francophone des Laboratoires, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1773035X11712151 Structural identification of modified amino acids on the interface between EPO and its receptor from EPO BRP, human recombinant erythropoietin by LC/MS KE Song, J Byeon, DB Moon, HH Kim, YJ Choi - Molecules and cells, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1016847823053797 Fabrication of an on-line enzyme micro-reactor coupled to liquid chromatography-tandem mass spectrometry for the digestion of recombinant human erythropoietin HC Foo, NW Smith, SMR Stanley - Talanta, 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0039914014010169 [28] Characterization of recombinant proteins HA Scoble, SA Martin - Methods in enzymology, 1990 - Elsevierhttps://www.sciencedirect.com/science/article/pii/007668799093436O Quantitative analysis of erythropoietin in human plasma by tandem mass spectrometry F Xuereb , S Chaignepain, D Breilh , F Godde - Analytical and , 2011 - Springerhttps://link.springer.com/article/10.1007/s00216-011-4897-3 Confirmatory Analysis of Continuous Erythropoietin Receptor Activator and Erythropoietin Analogues in Equine Plasma by LC-MS for Doping Control F Guan, CE Uboh, LR Soma, G Maylin, Z Jiang - Analytical , 2010 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ac102031w LC-MS/MS method for confirmation of recombinant human erythropoietin and darbepoetin alpha in equine plasma F Guan, CE Uboh, LR Soma, E Birks, J Chen - Analytical , 2007 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ac070135o Doping control analysis of filgrastim in equine plasma and its application to a co-administration study of filgrastim and recombinant human erythropoietin in the horse ENM Ho, WH Kwok , MY Lau, ASY Wong - of Chromatography a, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021967314003264 Low pg/mL Detection of rHuEPOs in Horse Plasma Employing High-Resolution MS C Dauly, P Garcia , J Louette, F Cormant, M Oppermann - static.thermoscientific.comhttps://static.thermoscientific.com/images/D22022~.pdf Detection of rHuEPOs in Horse Plasma Samples at Low pg/mL Levels Employing High-Resolution MS Strategies C Dauly, P Garcia , J Louette, F Cormant, M Oppermann - 2015 - researchgate.nethttps://www.researchgate.net/profile/Ludovic-Bailly-Chouriberry/publication/267782766_Detection_of_rHuEPOs_in_Horse_Plasma_Samples_at_Low_pgmL_Levels_Employing_High-Resolution_MS_Strategies_Detection_of_rHuEPOs_in_Horse_Plasma_Samples_at_Low_pgmL_Levels_Employing_High-Resolution_MS_Str/links/5587da6408aeb0cdade0e3de/Detection-of-rHuEPOs-in-Horse-Plasma-Samples-at-Low-pg-mL-Levels-Employing-High-Resolution-MS-Strategies-Detection-of-rHuEPOs-in-Horse-Plasma-Samples-at-Low-pg-mL-Levels-Employing-High-Resolution-MS-S.pdf

TAT-GluN2BCTM is a membrane-permeable peptide that selectively targets active DAPK1 (Death-associated protein kinase 1) for lysosomal degradation, thereby

Secondary SIL peptide for Dinutuximab detection and quantification

Peptide H-CREAGRKAC-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CREAGRKAC-OH include the following: Seek & Destroy, use of targeting peptides for cancer detection and drug delivery V Le Joncour , P Laakkonen - Bioorganic & medicinal chemistry, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0968089617311094 Peptide based molecules as protein-protein interaction inhibitors: Tools for chemical genetics and therapy S Roy, P Ghosh, N Sekhar Roy - Current Chemical , 2012 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/ccb/2012/00000006/00000002/art00006 Peptide-based drug delivery systems R Goyal, V Ramakrishnan - and Biology of Nanomaterials for Drug Delivery, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780128140314000027 Homing peptides for cancer therapy P Lingasamy , T Teesalu - Bio-nanomedicine for cancer therapy, 2021 - Springerhttps://link.springer.com/chapter/10.1007/978-3-030-58174-9_2 Peptide targeting of tumor lymph vessels P Laakkonen , L Zhang - Annals of the New York , 2008 - Wiley Online Libraryhttps://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1196/annals.1413.003 Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics A Gautam, P Kapoor, K Chaudhary - Current medicinal , 2014 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2014/00000021/00000021/art00005

A synthetic peptide for use as a blocking control in assays to test for specificity of TPRKB antibody, catalog no. 70R-4344

Custom research peptide; min purity 95%.

[Pyr3]-Amyloid Beta-Protein (Human, 3-42) is a fragment of the human amyloid beta protein that inhibits ion channels and ligand-activated receptors. It has been shown to be an inhibitor of ion channel activity in vitro. [Pyr3]-Amyloid Beta-Protein (Human, 3-42) is a synthetic peptide that can be used as a research tool for investigating the effects of amyloid beta protein on cell biology.